These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10718366)

  • 1. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.
    Watanabe M; Chigusa M; Takahashi H; Nakamura J; Tanaka H; Ohno T
    In Vitro Cell Dev Biol Anim; 2000 Feb; 36(2):104-9. PubMed ID: 10718366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
    Tang X; Zhang J; Chen Y; Lan Z; Wang C
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and characterization of a human ureteral cancer cell line producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Tanaka S; Iwasaki H; Nishida T; Watanabe R; Jouzaki H; Kikuchi M
    Hum Cell; 1991 Mar; 4(1):44-50. PubMed ID: 1888704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue.
    Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR
    J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and characterization of human pancreatic adenocarcinoma cell line SOJ producing carcinoembryonic antigen and carbohydrate antigen 19-9].
    Fujii Y; Sekiguchi M; Shiroko Y; Shimizu H; Sugawara I; Hasumi K; Eriguchi M; Ikeuchi T; Uchida H
    Hum Cell; 1990 Mar; 3(1):31-6. PubMed ID: 2083222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers as a diagnostic key for hilar cholangiocarcinoma.
    Juntermanns B; Radunz S; Heuer M; Hertel S; Reis H; Neuhaus JP; Vernadakis S; Trarbach T; Paul A; Kaiser GM
    Eur J Med Res; 2010 Aug; 15(8):357-61. PubMed ID: 20947473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between CA19-9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT-2).
    Iwamura T; Taniguchi S; Kitamura N; Yamanari H; Kojima A; Hidaka K; Setoguchi T; Katsuki T
    J Gastroenterol Hepatol; 1992; 7(5):512-9. PubMed ID: 1391733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
    Minato H; Nakanuma Y; Terada T
    Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and characterization of a human colonic cancer cell line expressing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Atari E; Watanabe K; Yamashita K
    Hum Cell; 1992 Jun; 5(2):174-9. PubMed ID: 1390419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.
    Yano H; Iemura A; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M
    J Hepatol; 1996 Apr; 24(4):413-22. PubMed ID: 8738727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen].
    Sujino H; Nagamori S; Fujise K; Hasumura S; Homma S; Matsuura T; Shimizu K; Niiya M; Kameda H
    Hum Cell; 1988 Jun; 1(2):250-5. PubMed ID: 2979202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment and characterization of strain KE-24 derived from human colonic cancer].
    Yamashita K; Atari E; Watanabe K; Shinoda H; Yokozawa M
    Hum Cell; 1991 Jun; 4(2):145-9. PubMed ID: 1958633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2).
    Iwamura T; Katsuki T
    Gastroenterol Jpn; 1987 Oct; 22(5):640-6. PubMed ID: 2445616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and characterization of human colonic and gastric cancer cell lines].
    Ide K; Iwamura T; Katsuki T
    Hum Cell; 1988 Jun; 1(2):245-9. PubMed ID: 2979201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological study of the TK cholangiocarcinoma cell line with three-dimensional cell culture.
    Akiyoshi K; Kamada M; Akiyama N; Suzuki M; Watanabe M; Fujioka K; Ikeda K; Mizuno S; Manome Y
    Mol Med Rep; 2014 Apr; 9(4):1359-64. PubMed ID: 24535710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Tao LY; Cai L; He XD; Liu W; Qu Q
    Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a newly established cell line (JR-St) derived from human gastric signet ring cell cancer, producing tumor markers.
    Terano A; Nakada R; Mutoh H; Hiraishi H; Ota S; Shiina S; Shimada T; Itoh Y; Kimura K; Shiga J
    Gastroenterol Jpn; 1991 Feb; 26(1):7-13. PubMed ID: 1848829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of the human cholangiocarcinoma cell line HChol-Y1 in a serum-free, chemically defined medium.
    Yamaguchi N; Morioka H; Ohkura H; Hirohashi S; Kawai K
    J Natl Cancer Inst; 1985 Jul; 75(1):29-35. PubMed ID: 2989602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.